OBJECTIVE: A functional promoter polymorphism in the monoamine oxidase A (MAOA) gene has been implicated in neuropsychiatric disorders and also moderates the association between early-life stress and mental disorders, which often co-occur with cardiovascular disease. No study has examined the relationship between MAOA genotype, childhood trauma, and subclinical atherosclerosis. The objective of this investigation was to examine whether childhood trauma moderates the association between MAOA genotype and subclinical atherosclerosis. METHODS: A sample including 289 middle-aged male twin pairs was studied. Subclinical atherosclerosis was assessed by brachial flow-mediated dilation (FMD) using ultrasound. Childhood trauma, before age 18 years, was measured with the Early Trauma Inventory and included physical, emotional, and sexual abuse as well as general trauma. Generalized estimating equation models were used to test the main and interactive effects of the MAOA genotype and each domain of childhood trauma on FMD, adjusting for known risk factors. RESULTS: General trauma was the most prevalent childhood trauma (28.4%), followed by physical abuse (25.0%), emotional abuse (19.4%), and sexual abuse (11.6%). MAOA genotype was not associated with any domain of childhood trauma. There was no significant evidence for a main effect for the MAOA genotype (β = .02, p = .82) or childhood trauma (.005 < β < .10, p > .54) FMD. However, a significant interaction was observed between MAOA genotype and physical (β interaction = .37, p = .026) or emotional abuse (β interaction = .43, p = .025) on subclinical atherosclerosis. CONCLUSIONS: Childhood trauma modulates the impact of MAOA variant on subclinical atherosclerosis, independent of traditional cardiovascular risk factors.
OBJECTIVE: A functional promoter polymorphism in the monoamine oxidase A (MAOA) gene has been implicated in neuropsychiatric disorders and also moderates the association between early-life stress and mental disorders, which often co-occur with cardiovascular disease. No study has examined the relationship between MAOA genotype, childhood trauma, and subclinical atherosclerosis. The objective of this investigation was to examine whether childhood trauma moderates the association between MAOA genotype and subclinical atherosclerosis. METHODS: A sample including 289 middle-aged male twin pairs was studied. Subclinical atherosclerosis was assessed by brachial flow-mediated dilation (FMD) using ultrasound. Childhood trauma, before age 18 years, was measured with the Early Trauma Inventory and included physical, emotional, and sexual abuse as well as general trauma. Generalized estimating equation models were used to test the main and interactive effects of the MAOA genotype and each domain of childhood trauma on FMD, adjusting for known risk factors. RESULTS: General trauma was the most prevalent childhood trauma (28.4%), followed by physical abuse (25.0%), emotional abuse (19.4%), and sexual abuse (11.6%). MAOA genotype was not associated with any domain of childhood trauma. There was no significant evidence for a main effect for the MAOA genotype (β = .02, p = .82) or childhood trauma (.005 < β < .10, p > .54) FMD. However, a significant interaction was observed between MAOA genotype and physical (β interaction = .37, p = .026) or emotional abuse (β interaction = .43, p = .025) on subclinical atherosclerosis. CONCLUSIONS:Childhood trauma modulates the impact of MAOA variant on subclinical atherosclerosis, independent of traditional cardiovascular risk factors.
Authors: Maxia Dong; Wayne H Giles; Vincent J Felitti; Shanta R Dube; Janice E Williams; Daniel P Chapman; Robert F Anda Journal: Circulation Date: 2004-09-20 Impact factor: 29.690
Authors: Rickard L Sjöberg; Kent W Nilsson; Hanna-Linn Wargelius; Jerzy Leppert; Leif Lindström; Lars Oreland Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-03-05 Impact factor: 3.568
Authors: David Huizinga; Brett C Haberstick; Andrew Smolen; Scott Menard; Susan E Young; Robin P Corley; Michael C Stallings; Jennifer Grotpeter; John K Hewitt Journal: Biol Psychiatry Date: 2006-10-01 Impact factor: 13.382
Authors: Jeffrey F Scherrer; Hong Xian; Kathleen K Bucholz; Seth A Eisen; Michael J Lyons; Jack Goldberg; Ming Tsuang; William R True Journal: Psychosom Med Date: 2003 Jul-Aug Impact factor: 4.312
Authors: Debra L Foley; Lindon J Eaves; Brandon Wormley; Judy L Silberg; Hermine H Maes; Jonathan Kuhn; Brien Riley Journal: Arch Gen Psychiatry Date: 2004-07
Authors: Yung-Yu Huang; Sarah P Cate; Cristina Battistuzzi; Maria A Oquendo; David Brent; J John Mann Journal: Neuropsychopharmacology Date: 2004-08 Impact factor: 7.853
Authors: Andrea Danese; Carmine M Pariante; Avshalom Caspi; Alan Taylor; Richie Poulton Journal: Proc Natl Acad Sci U S A Date: 2007-01-17 Impact factor: 11.205
Authors: Matthew T Wittbrodt; Kasra Moazzami; Bruno B Lima; Zuhayr S Alam; Daniel Corry; Muhammad Hammadah; Carolina Campanella; Laura Ward; Arshed A Quyyumi; Amit J Shah; Viola Vaccarino; Jonathon A Nye; J Douglas Bremner Journal: J Affect Disord Date: 2019-05-11 Impact factor: 4.839
Authors: Amit J Shah; Virginia Weeks; Rachel Lampert; J Douglas Bremner; Michael Kutner; Paolo Raggi; Yan V Sun; Tené T Lewis; Oleksiy Levantsevych; Ye Ji Kim; Muhammad Hammadah; Ayman Alkhoder; Matthew Wittbrodt; Brad D Pearce; Laura Ward; David Sheps; Arshed A Quyyumi; Viola Vaccarino Journal: J Am Heart Assoc Date: 2022-02-15 Impact factor: 6.106